Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
153.03
+0.95 (0.62%)
At close: Jul 30, 2025, 4:00 PM
153.22
+0.19 (0.12%)
After-hours: Jul 30, 2025, 4:00 PM EDT
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $4.42 billion as of July 30, 2025. Its market cap has decreased by -23.77% in one year.
Market Cap
4.42B
Enterprise Value
3.72B
1-Year Change
-23.77%
Ranking
Category
Stock Price
$153.03
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $102.60M to $4.42B, an increase of 4,210.12%. That is a compound annual growth rate of 61.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 4.39B | -2.46% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 17.08% |
| Dec 31, 2021 | 1.74B | 47.34% |
| Dec 31, 2020 | 1.18B | 23.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.47B |
| Johnson & Johnson | 400.31B |
| AbbVie | 333.00B |
| Novo Nordisk | 311.87B |
| UnitedHealth Group | 255.92B |
| Novartis AG | 225.40B |
| AstraZeneca | 224.29B |
| Abbott Laboratories | 219.83B |